These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34995453)

  • 41. Bifunctional opioid receptor ligands as novel analgesics.
    Cunningham CW; Elballa WM; Vold SU
    Neuropharmacology; 2019 Jun; 151():195-207. PubMed ID: 30858102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Search for the "ideal analgesic" in pain treatment by engineering the mu-opioid receptor.
    Tao PL; Law PY; Loh HH
    IUBMB Life; 2010 Feb; 62(2):103-11. PubMed ID: 20039371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Designing safer analgesics: a focus on μ-opioid receptor pathways.
    Pergolizzi JV; LeQuang JA; Taylor R; Ossipov MH; Colucci D; Raffa RB
    Expert Opin Drug Discov; 2018 Oct; 13(10):965-972. PubMed ID: 30175624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
    Gallantine EL; Meert TF
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
    Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
    Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates.
    Ding H; Czoty PW; Kiguchi N; Cami-Kobeci G; Sukhtankar DD; Nader MA; Husbands SM; Ko MC
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5511-8. PubMed ID: 27573832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. L-type and T-type calcium channel blockade potentiate the analgesic effects of morphine and selective mu opioid agonist, but not to selective delta and kappa agonist at the level of the spinal cord in mice.
    Doğrul A; Yeşilyurt Ö; Işmer A; Güzeldemir EM
    Pain; 2001 Jul; 93(1):61-68. PubMed ID: 11406339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system.
    King MA; Bradshaw S; Chang AH; Pintar JE; Pasternak GW
    J Neurosci; 2001 Oct; 21(19):7788-92. PubMed ID: 11567069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo effects of μ-opioid receptor agonist/δ-opioid receptor antagonist peptidomimetics following acute and repeated administration.
    Anand JP; Kochan KE; Nastase AF; Montgomery D; Griggs NW; Traynor JR; Mosberg HI; Jutkiewicz EM
    Br J Pharmacol; 2018 Jun; 175(11):2013-2027. PubMed ID: 29352503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The combination of opioid and neurotensin receptor agonists improves their analgesic/adverse effect ratio.
    Eiselt E; Côté J; Longpré JM; Blais V; Sarret P; Gendron L
    Eur J Pharmacol; 2019 Apr; 848():80-87. PubMed ID: 30707956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of Carfentanil Amide Opioids Using the Ugi Multicomponent Reaction.
    Váradi A; Palmer TC; Haselton N; Afonin D; Subrath JJ; Le Rouzic V; Hunkele A; Pasternak GW; Marrone GF; Borics A; Majumdar S
    ACS Chem Neurosci; 2015 Sep; 6(9):1570-7. PubMed ID: 26148793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The emerging therapeutic roles of κ-opioid agonists.
    Jones MR; Kaye AD; Kaye AJ; Urman RD
    J Opioid Manag; 2016; 12(2):101-7. PubMed ID: 27194194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications.
    Vardanyan RS; Hruby VJ
    Future Med Chem; 2014 Mar; 6(4):385-412. PubMed ID: 24635521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cross-tolerance to acute administration of mu and kappa opioid agonists at the spinal cord level in the rat.
    Laurido C; Hernandez A; Perez H
    Int J Neurosci; 1996 Nov; 87(3-4):191-9. PubMed ID: 9003979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. On the Role of Peripheral Sensory and Gut Mu Opioid Receptors: Peripheral Analgesia and Tolerance.
    Fürst S; Zádori ZS; Zádor F; Király K; Balogh M; László SB; Hutka B; Mohammadzadeh A; Calabrese C; Galambos AR; Riba P; Romualdi P; Benyhe S; Timár J; Schmidhammer H; Spetea M; Al-Khrasani M
    Molecules; 2020 May; 25(11):. PubMed ID: 32466522
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilities.
    Healy JR; Bezawada P; Shim J; Jones JW; Kane MA; MacKerell AD; Coop A; Matsumoto RR
    ACS Chem Neurosci; 2013 Sep; 4(9):1256-66. PubMed ID: 23713721
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pain inhibition by opioids-new concepts].
    Stein C
    Anaesthesist; 2019 Feb; 68(2):97-103. PubMed ID: 30645691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The search for opioid analgesics with limited tolerance liability.
    Wtorek K; Piekielna-Ciesielska J; Janecki T; Janecka A
    Peptides; 2020 Aug; 130():170331. PubMed ID: 32497566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.